Clinical Trials Arena April 12, 2024
GlobalData

At CTS New England 2024, clinical trial supply managers were called to leverage technology to reduce the risk of drug shortages in clinical trials.

As clinical trials become more complex, drug shortages are one of the biggest challenges in clinical trial supply management. They’re also on the rise – with a 2022 poll showing 83% of pharmaceutical companies reported experiencing supply chain risks in the past 24 months.

These drug shortages can have potentially devastating consequences if life-saving drugs are unavailable to patients, risking their treatment and the success of the trial.

Speaking at the Clinical Trial Supply New England 2024 conference, Maxime Derep, senior solutions engineer at deep tech software company N-SIDE urged companies to leverage technological solutions to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Conferences / Podcast, Pharma, Pharma / Biotech, Trends
STAT+: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial
Oh, Canada: U.S. Patients Don't Want Your Health Policies
STAT+: House bill aimed at Chinese biotechs is advancing
STAT+: Pharmalittle: We’re reading about MorphoSys drug risks, an AstraZeneca admission, and more
Steep Ozempic, Wegovy prices face fresh scrutiny from officials

Share This Article